Company Filing History:
Years Active: 2018-2023
Title: Katharina Bayer: Innovator in CMV Vaccine Development
Introduction
Katharina Bayer is a prominent inventor based in Mistelbach, Austria. She has made significant contributions to the field of medical research, particularly in the development of vaccines for cytomegalovirus (CMV) infections. With a total of two patents to her name, Bayer is recognized for her innovative approaches to vaccine technology.
Latest Patents
Bayer's latest patents focus on genetically modified arenaviral vectors that are suitable as vaccines for the prevention and treatment of cytomegalovirus infections and reactivation. These patents also encompass pharmaceutical compositions and methods aimed at treating CMV infections. Specifically, her work includes the development of pharmaceutical compositions, vaccines, and methods for effectively addressing cytomegalovirus infections and reactivation.
Career Highlights
Katharina Bayer is associated with Hookipa Biotech GmbH, where she continues to advance her research in vaccine development. Her work is pivotal in the ongoing efforts to combat CMV, a virus that can lead to serious health complications, particularly in immunocompromised individuals.
Collaborations
Bayer collaborates with notable colleagues, including Klaus Orlinger and Karen Lingnau, who contribute to her research endeavors and the advancement of vaccine technology.
Conclusion
Katharina Bayer's innovative work in CMV vaccine development highlights her significant role in medical research. Her contributions are vital for improving treatment options for cytomegalovirus infections, showcasing her dedication to advancing public health.